Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Rapid Hepatomegaly From Ruxolitinib Discontinuation Syndrome.
Journal: HCA healthcare journal of medicine
Published: July 10, 2023
A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 23, 2013
A phase I, dose-escalation study of cyclical weekly oral temozolomide and weekly PEG-interferon alpha-2b in patients with refractory or advanced solid tumours.
Journal: Journal of chemotherapy (Florence, Italy)
Published: October 08, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026